ARCH Venture Fund XII, L.P. → Neumora Therapeutics, Inc. NMRA

Stake: 18.70% Shares: 33,847,838 CUSIP: 640979100 Class: Common Stock, $0.0001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 4.03

4,326,409 shares short · -12.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $6.58M

Point72 Asset Mgmt

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →